Related references
Note: Only part of the references are listed.Simvastatin Attenuates Radiation-Induced Murine Lung Injury and Dysregulated Lung Gene Expression
Biji Mathew et al.
AMERICAN JOURNAL OF RESPIRATORY CELL AND MOLECULAR BIOLOGY (2011)
Potential use of HMG-CoA reductase inhibitors (statins) as radioprotective agents
Gerhard Fritz et al.
BRITISH MEDICAL BULLETIN (2011)
MYC Phosphorylation, Activation, and Tumorigenic Potential in Hepatocellular Carcinoma Are Regulated by HMG-CoA Reductase
Zhongwei Cao et al.
CANCER RESEARCH (2011)
Hallmarks of Cancer: The Next Generation
Douglas Hanahan et al.
CELL (2011)
AMPK Phosphorylates and Inhibits SREBP Activity to Attenuate Hepatic Steatosis and Atherosclerosis in Diet-Induced Insulin-Resistant Mice
Yu Li et al.
CELL METABOLISM (2011)
Statin Prescriptions and Breast Cancer Recurrence Risk: A Danish Nationwide Prospective Cohort Study
Thomas P. Ahern et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2011)
Statin Use and Risk of Prostate Cancer in a Population of Men Who Underwent Biopsy
Nelly Tan et al.
JOURNAL OF UROLOGY (2011)
Blood lipid levels and prostate cancer risk; a cohort study
D. E. G. Kok et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2011)
Regulation of cancer cell metabolism
Rob A. Cairns et al.
NATURE REVIEWS CANCER (2011)
Exploiting the mevalonate pathway to distinguish statin-sensitive multiple myeloma
James W. Clendening et al.
BLOOD (2010)
Lovastatin induces apoptosis of ovarian cancer cells and synergizes with doxorubicin: potential therapeutic relevance
Anna Martirosyan et al.
BMC CANCER (2010)
Fluvastatin reduces proliferation and increases apoptosis in women with high grade breast cancer
Elisabeth R. Garwood et al.
BREAST CANCER RESEARCH AND TREATMENT (2010)
A Transcriptional Signature and Common Gene Networks Link Cancer with Lipid Metabolism and Diverse Human Diseases
Heather A. Hirsch et al.
CANCER CELL (2010)
Targeting Mitochondrial Glutaminase Activity Inhibits Oncogenic Transformation
Jian-Bin Wang et al.
CANCER CELL (2010)
Lipophilic Statin Use and Risk of Breast Cancer Subtypes
Stephan Woditschka et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2010)
Atorvastatin increases expression of low-density lipoprotein receptor mRNA in human circulating mononuclear cells
Anothai Pocathikorn et al.
CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY (2010)
The addition of pravastatin to chemotherapy in advanced gastric carcinoma: A randomised phase II trial
Inge R. H. M. Konings et al.
EUROPEAN JOURNAL OF CANCER (2010)
Statin use and cancer risk: a comprehensive review
Denise M. Boudreau et al.
EXPERT OPINION ON DRUG SAFETY (2010)
Differential interactions between statins and P-glycoprotein: implications for exploiting statins as anticancer agents
Carolyn A. Goard et al.
INTERNATIONAL JOURNAL OF CANCER (2010)
A systematic review and meta-analysis on the therapeutic equivalence of statins
T. -C. Weng et al.
JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS (2010)
Dysregulation of the mevalonate pathway promotes transformation
James W. Clendening et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2010)
Simvastatin plus irinotecan, 5-fluorouracil, and leucovorin (FOLFIRI) as first-line chemotherapy in metastatic colorectal patients: a multicenter phase II study
Jeeyun Lee et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2009)
Potential immunologic effects of statins in cancer following transplantation
J. E. Fildes et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2009)
Oncogenic KRAS and BRAF Differentially Regulate Hypoxia-inducible Factor-1α and-2α in Colon Cancer
Hirotoshi Kikuchi et al.
CANCER RESEARCH (2009)
被撤回的出版物: A Pleiotropically Acting MicroRNA, miR-31, Inhibits Breast Cancer Metastasis (Retracted article. See vol. 161, pg. 417, 2015)
Scott Valastyan et al.
CELL (2009)
Targeting the Mevalonate Pathway for Improved Anticancer Therapy
G. Fritz
CURRENT CANCER DRUG TARGETS (2009)
Statins Are Associated With a Reduced Risk of Hepatocellular Carcinoma in a Large Cohort of Patients With Diabetes
Hashem B. El-Serag et al.
GASTROENTEROLOGY (2009)
A phase II clinical trial does not show that high dose simvastatin has beneficial effect on markers of bone turnover in multiple myeloma
T. E. Sondergaard et al.
HEMATOLOGICAL ONCOLOGY (2009)
Cholesterol feedback: from Schoenheimer's bottle to Scap's MELADL
Michael S. Brown et al.
JOURNAL OF LIPID RESEARCH (2009)
Fatty Acid Synthase: A Metabolic Enzyme and Candidate Oncogene in Prostate Cancer
Toshiro Migita et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Common corruption of the mTOR signaling network in human tumors
S Menon et al.
ONCOGENE (2009)
Lovastatin attenuates ionizing radiation-induced normal tissue damage in vivo
Christian Ostrau et al.
RADIOTHERAPY AND ONCOLOGY (2009)
Glucose Deprivation Contributes to the Development of KRAS Pathway Mutations in Tumor Cells
Jihye Yun et al.
SCIENCE (2009)
Phase II study of metronomic chemotherapy with thalidomide, carboplatin-vincristine-fluvastatin in the treatment of brain stem tumors in children
Enrique Lopez-Aguilar et al.
ARCHIVES OF MEDICAL RESEARCH (2008)
The TSC1-TSC2 complex: a molecular switchboard controlling cell growth
Jingxiang Huang et al.
BIOCHEMICAL JOURNAL (2008)
Reversal of chemoresistance and enhancement of apoptosis by statins through down-regulation of the NF-κB pathway
Kwang Seok Ahn et al.
BIOCHEMICAL PHARMACOLOGY (2008)
Tumor cell metabolism: Cancer's Achilles' heel
Guido Kroemer et al.
CANCER CELL (2008)
Estrogen receptor-negative breast cancer is less likely to arise among lipophilic statin users
Anjali S. Kumar et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2008)
SREBP activity is regulated by mTORC1 and contributes to Akt-dependent cell growth
Thomas Porstmann et al.
CELL METABOLISM (2008)
The biology of cancer: Metabolic reprogramming fuels cell growth and proliferation
Ralph J. DeBerardinis et al.
CELL METABOLISM (2008)
Chemoembolization Combined with Pravastatin Improves Survival in Patients with Hepatocellular Carcinoma
Hannah Graf et al.
DIGESTION (2008)
Statins and cancer: A systematic review and meta-analysis
Jaana Kuoppala et al.
EUROPEAN JOURNAL OF CANCER (2008)
Statins and cancer: a meta-analysis of case-control studies
Marcia L. Taylor et al.
EUROPEAN JOURNAL OF CANCER PREVENTION (2008)
AMP-activated protein kinase and human cancer: cancer metabolism revisited
F. P. Kuhajda
INTERNATIONAL JOURNAL OF OBESITY (2008)
Regulation of HMG-CoA reductase expression by hypoxia
Valentina Pallottini et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2008)
PI3K pathway alterations in cancer: variations on a theme
T. L. Yuan et al.
ONCOGENE (2008)
Post-diagnosis statin use and breast cancer recurrence in a prospective cohort study of early stage breast cancer survivors
Marilyn L. Kwan et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Bax activation and stress-induced apoptosis delayed by the accumulation of cholesterol in mitochondrial membranes
S. Lucken-Ardjomande et al.
CELL DEATH AND DIFFERENTIATION (2008)
High dose Simvastatin does not reverse resistance to Vincristine, Adriamycin, and Dexamethasone (VAD) in Myeloma
E. van der Spek et al.
HAEMATOLOGICA (2007)
Comparative evaluation of the effects of statins on human stem and cancer cells in vitro
Kalarnegarn Gauthaman et al.
REPRODUCTIVE BIOMEDICINE ONLINE (2007)
First clinical experience with simvastatin to overcome drug resistance in refractory multiple myeloma
Ralf Schmidmaier et al.
EUROPEAN JOURNAL OF HAEMATOLOGY (2007)
Post-translational modifications and regulation of the RAS superfamily of GTPases as anticancer targets
Panagiotis A. Konstantinopoulos et al.
NATURE REVIEWS DRUG DISCOVERY (2007)
Statins Disrupt CCR5 and RANTES Expression Levels in CD4+ T Lymphocytes In Vitro and Preferentially Decrease Infection of R5 Versus X4 HIV-1
Alexey A. Nabatov et al.
PLOS ONE (2007)
PRAS40 is an insulin-regulated inhibitor of the mTORC1 protein kinase
Yasemin Sancak et al.
MOLECULAR CELL (2007)
Statin use and breast cancer risk in a large population-based setting
Denise M. Boudreau et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2007)
Lipophilic statins suppress cytotoxicity by freshly isolated natural killer cells through modulation of granule exocytosis
Toru Tanaka et al.
INTERNATIONAL IMMUNOLOGY (2007)
Cerivastatin reduces cytokine-induced surface expression of ICAM-1 via increased shedding in human endothelial cells
Martin Landsberger et al.
ATHEROSCLEROSIS (2007)
Determinants of sensitivity to lovastatin-induced apoptosis in multiple myeloma
W. Wei-Lynn Wong et al.
MOLECULAR CANCER THERAPEUTICS (2007)
The inflammation hypothesis and its potential relevance to statin therapy
James S. Forrester et al.
AMERICAN JOURNAL OF CARDIOLOGY (2007)
Statin-induced apoptosis and skeletal myopathy
Amie J. Dirks et al.
AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY (2006)
Pharmacokinetic and pharmacodynamic alterations of 3-hydroxy-3-methylglutaryl coenzyme A (HMG-CoA) reductase inhibitors: Drug-drug interactions and interindividual differences in transporter and metabolic enzyme functions
Yoshihisa Shitara et al.
PHARMACOLOGY & THERAPEUTICS (2006)
Cancer's molecular sweet tooth and the Warburg effect
Jung-whan Kim et al.
CANCER RESEARCH (2006)
Simvastatin modulates chemokine and chemokine receptor expression by geranylgeranyl isoprenoid pathway in human endothelial cells and macrophages
Niels R. Veillard et al.
ATHEROSCLEROSIS (2006)
Breast cancer growth prevention by statins
Michael J. Campbell et al.
CANCER RESEARCH (2006)
AMPK and cell proliferation - AMPK as a therapeutic target for atherosclerosis and cancer
Hiroyuki Motoshima et al.
JOURNAL OF PHYSIOLOGY-LONDON (2006)
Statin use and breast cancer: Prospective results from the Women's Health Initiative
JA Cauley et al.
JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Rho GTPases and leukocyte adhesion receptor expression and function in endothelial cells
E Cernuda-Morollón et al.
CIRCULATION RESEARCH (2006)
Apocrine cysts of the breast -: Biomarkers, origin, enlargement, and relation with cancer phenotype
JE Celis et al.
MOLECULAR & CELLULAR PROTEOMICS (2006)
Are statins created equal? Evidence from randomized trials of pravastatin, simvastatin, and atorvastatin for cardiovascular disease prevention
Z Zhou et al.
AMERICAN HEART JOURNAL (2006)
Lovastatin protects human endothelial cells from killing by ionizing radiation without impairing induction and repair of DNA double-strand breaks
T Nübel et al.
CLINICAL CANCER RESEARCH (2006)
Pharmacodynamic effects of high dose lovastatin in subjects with advanced malignancies
SA Holstein et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2006)
Statins and cancer risk - A meta-analysis
KM Dale et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2006)
Choline kinase: An important target for cancer
S Janardhan et al.
CURRENT MEDICINAL CHEMISTRY (2006)
Use of statins and breast cancer: A meta-analysis of seven randomized clinical trials and nine observational studies
S Bonovas et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Muscle coenzyme Q10 level in statin-related myopathy
C Lamperti et al.
ARCHIVES OF NEUROLOGY (2005)
The potential relevance of the multiple lipid-independent (Pleiotropic) effects of statins in the management of acute coronary syndromes
KK Ray et al.
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY (2005)
Intermolecular differences of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitors contribute to distinct pharmacologic and pleiotropic actions
RP Mason et al.
AMERICAN JOURNAL OF CARDIOLOGY (2005)
Combining prenylation inhibitors causes synergistic cytotoxicity, apoptosis and disruption of RAS-to-MAP kinase signalling in multiple myeloma cells
MA Morgan et al.
BRITISH JOURNAL OF HAEMATOLOGY (2005)
ATP citrate lyase is an important component of cell growth and transformation
DE Bauer et al.
ONCOGENE (2005)
Association of statin use with a pathologic complete response to neoadjuvant chemoradiation for rectal cancer
MS Katz et al.
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS (2005)
Identification of molecular apocrine breast tumours by microarray analysis
P Farmer et al.
ONCOGENE (2005)
Effect of fluvastatin on apoptosis in human CD4+ T cells
KTR Samson et al.
CELLULAR IMMUNOLOGY (2005)
Statins and the risk of colorectal cancer
JN Poynter et al.
NEW ENGLAND JOURNAL OF MEDICINE (2005)
Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements
A Rarnanathan et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
A Phase I trial of prolonged administration of lovastatin in patients with recurrent or metastatic squamous cell carcinoma of the head and neck or of the cervix
JJ Knox et al.
EUROPEAN JOURNAL OF CANCER (2005)
Therapy Insight: potential of statins for cancer chemoprevention and therapy
MS Katz
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
Altered Rho GTPase signaling pathways in breast cancer cells
P Burbelo et al.
BREAST CANCER RESEARCH AND TREATMENT (2004)
Cholesterol synthesis and import contribute to protective cholesterol increments in acute myeloid leukemia cells
DE Banker et al.
BLOOD (2004)
Overexpression of RhoA, Rac1, and Cdc42 GTPases is associated with progression in testicular cancer
T Kamai et al.
CLINICAL CANCER RESEARCH (2004)
The LKB1 tumor suppressor negatively regulates mTOR signaling
RJ Shaw et al.
CANCER CELL (2004)
Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes
B Altenberg et al.
GENOMICS (2004)
Simvastatin induces death of multiple myeloma cell lines
N Gronich et al.
JOURNAL OF INVESTIGATIVE MEDICINE (2004)
Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial
DW McCarey et al.
LANCET (2004)
The risk of cancer in users of statins
MR Graaf et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Simvastatin increases bone mineral density in hypercholesterolemic postmenopausal women
G Lupattelli et al.
METABOLISM-CLINICAL AND EXPERIMENTAL (2004)
Lovastatin causes sensitization of HeLa cells to ionizing radiation-induced apoptosis by the abrogation of G2 blockage
G Fritz et al.
INTERNATIONAL JOURNAL OF RADIATION BIOLOGY (2003)
Lovastatin and beyond: The history of the HMG-CoA reductase inhibitors
JA Tobert
NATURE REVIEWS DRUG DISCOVERY (2003)
Cholesterol-modulating agents kill acute myeloid leukemia cells and sensitize them to therapeutics by blocking adaptive cholesterol responses
HY Li et al.
BLOOD (2003)
Mevastatin can increase toxicity in primary AMLs exposed to standard therapeutic agents, but statin efficacy is not simply associated with ras hotspot mutations or overexpression
DL Stirewalt et al.
LEUKEMIA RESEARCH (2003)
Therapy with statins in patients with refractory rheumatic diseases: a preliminary study
C Abud-Mendoza et al.
LUPUS (2003)
Rho GTPases in cell biology
S Etienne-Manneville et al.
NATURE (2002)
Immunomodulation of experimental autoimmune encephalomyelitis in the Lewis rats by Lovastatin
R Stanislaus et al.
NEUROSCIENCE LETTERS (2002)
Cerivastatin enhances the cytotoxicity of 5-fluorouracil on chemosensitive and resistant colorectal cancer cell lines
WG Wang et al.
FEBS LETTERS (2002)
The HMG-CoA reductase inhibitor, atorvastatin, promotes a Th2 bias and reverses paralysis in central nervous system autoimmune disease
S Youssef et al.
NATURE (2002)
Changes in human plasma levels of the brain specific oxysterol 24S-hydroxycholesterol during progression of multiple sclerosis
V Leoni et al.
NEUROSCIENCE LETTERS (2002)
Rho GTPases in human breast tumours: expression and mutation analyses and correlation with clinical parameters
G Fritz et al.
BRITISH JOURNAL OF CANCER (2002)
MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20536 high-risk individuals: a randomised placebo-controlled trial
R Collins et al.
LANCET (2002)
The cholesterol lowering drug lovastatin induces cell death in myeloma plasma cells
NWCJ van de Donk et al.
LEUKEMIA (2002)
Lovastatin potentiates antitumor activity of doxorubicin in murine melanoma via an apoptosis-dependent mechanism
W Feleszko et al.
INTERNATIONAL JOURNAL OF CANCER (2002)
HMG-CoA reductase inhibitors and the malignant cell: the statin family of drugs as triggers of tumor-specific apoptosis
WWL Wong et al.
LEUKEMIA (2002)
Reduction of plasma 24S-hydroxycholesterol (cerebrosterol) levels using high-dosage simvastatin in patients with hypercholesterolemia -: Evidence that simvastatin affects cholesterol metabolism in the human brain
S Locatelli et al.
ARCHIVES OF NEUROLOGY (2002)
Characterization of RhoC expression in benign and malignant breast disease - A potential new marker for small breast carcinomas with metastatic ability
CG Kleer et al.
AMERICAN JOURNAL OF PATHOLOGY (2002)
HMG-CoA reductase inhibitor mevastatin enhances the growth inhibitory effect of butyrate in the colorectal carcinoma cell line Caco-2
A Wächtershäuser et al.
CARCINOGENESIS (2001)
Structural mechanism for statin inhibition of HMG-CoA reductase
ES Istvan et al.
SCIENCE (2001)
Effect of pravastatin on survival in patients with advanced hepatocellular carcinoma. A randomized controlled trial
S Kawata et al.
BRITISH JOURNAL OF CANCER (2001)
Regulation of glut1 mRNA by hypoxia-inducible factor-1 -: Interaction between H-ras and hypoxia
CH Chen et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2001)
Lovastatin induced control of blast cell growth in an elderly patient with acute myeloblastic leukemia
MD Minden et al.
LEUKEMIA & LYMPHOMA (2001)
Phase II study of high-dose lovastatin in patients with advanced gastric adenocarcinoma
WS Kim et al.
INVESTIGATIONAL NEW DRUGS (2001)
Overexpression of RhoA mRNA is associated with advanced stage in testicular germ cell tumour
T Kamai et al.
BJU INTERNATIONAL (2001)
Safety profiles for the HMG-CoA reductase inhibitors - Treatment and trust
MH Davidson
DRUGS (2001)
NK-104: a novel synthetic HMG-CoA reductase inhibitor
K Kajinami et al.
EXPERT OPINION ON INVESTIGATIONAL DRUGS (2000)
Genomic analysis of metastasis reveals an essential role for RhoC
EA Clark et al.
NATURE (2000)
HMG-CoA reductase inhibitors and the risk of fractures
CR Meier et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
HMG-CoA reductase inhibitors and the risk of hip fractures in elderly patients
PS Wang et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2000)
Rac1 in human breast cancer: overexpression, mutation analysis, and characterization of a new isoform, Rac1b
A Schnelzer et al.
ONCOGENE (2000)
Endogenous, hyperactive Rac3 controls proliferation of breast cancer cells by a p21-activated kinase-dependent pathway
JP Mira et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2000)
Share Paper
